Clinical Trial Update: Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection [Phase 2]

View source ↗

Summary

Phase 2 trial of revaccinating healthy adolescents with the BCG vaccine to prevent sustained Mycobacterium tuberculosis infection has been terminated, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacille Calmette-Guérin) (Bacille Calmette-Guérin vaccine)

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Tuberculosis | Phase 2 | Status: TERMINATED | Results posted: 2025-06-19